Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothee Wernet

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer Immunology, Immunotherapy : CII|July 28, 2007
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cellsDespina Rudolf, Tobias Silberzahn, Steffen Walter, et al.
Cancer Research|October 18, 2002
Integrated functional genomics approach for the design of patient-individual antitumor vaccinesToni Weinschenk, Cécile Gouttefangeas, Markus Schirle, et al.
Cancer Immunology, Immunotherapy : CII|February 3, 2009
HLA ligand profiles of primary renal cell carcinoma maintained in metastasesJuliane Sarah Stickel, Andreas O Weinzierl, Nina Hillen, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2007
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptidesMorgan G Mathieu, Ashley J Knights, Graham Pawelec, et al.
International Journal of Cancer|August 23, 2011
Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patientsMelanie Widenmeyer, Heinrich Griesemann, Stefan Stevanović, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2015
Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clustersCécile Gouttefangeas, Cliburn Chan, Sebastian Attig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomasJörn Dengjel, Maria-Dorothea Nastke, Cécile Gouttefangeas, et al.
International Journal of Cancer|August 18, 2010
Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablationMelanie Widenmeyer, Yuriy Shebzukhov, Sebastian P Haen, et al.
Plos One|April 7, 2015
Alpha-synuclein levels in blood plasma decline with healthy agingNiklas K U Koehler, Elke Stransky, Mirjam Meyer, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Immunology, Immunotherapy : CII|July 28, 2007
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cellsDespina Rudolf, Tobias Silberzahn, Steffen Walter, et al.
Cancer Research|October 18, 2002
Integrated functional genomics approach for the design of patient-individual antitumor vaccinesToni Weinschenk, Cécile Gouttefangeas, Markus Schirle, et al.
Cancer Immunology, Immunotherapy : CII|February 3, 2009
HLA ligand profiles of primary renal cell carcinoma maintained in metastasesJuliane Sarah Stickel, Andreas O Weinzierl, Nina Hillen, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2007
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptidesMorgan G Mathieu, Ashley J Knights, Graham Pawelec, et al.
International Journal of Cancer|August 23, 2011
Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patientsMelanie Widenmeyer, Heinrich Griesemann, Stefan Stevanović, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2015
Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clustersCécile Gouttefangeas, Cliburn Chan, Sebastian Attig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomasJörn Dengjel, Maria-Dorothea Nastke, Cécile Gouttefangeas, et al.
International Journal of Cancer|August 18, 2010
Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablationMelanie Widenmeyer, Yuriy Shebzukhov, Sebastian P Haen, et al.
Plos One|April 7, 2015
Alpha-synuclein levels in blood plasma decline with healthy agingNiklas K U Koehler, Elke Stransky, Mirjam Meyer, et al.
Pageof 3